The Crafty Vet Project aims to ignite your interest in one of a range of creative hobbies, which include cheese, beer, candle, soap and teddy-bear making, with kits available for sale from the new 'Craft Corner' section of their website. £3 from the sale of each kit will go to Vetlife.
Sarah said: "We wanted other veterinary professionals to experience the same pleasure that we get from creative hobbies. It is a chance for people no matter what day you have had to switch off, follow a pattern or instructions and come out with something at the end that you can be truly proud of."
Your new hobby might even turn into a nice sideline business. Sarah said: "One evening over a catch-up Zoe and I were discussing items that we wished we had in practice to make our lives as nurses easier.
"Despite having drunk 2 bottles of wine together we felt that there and then was the best time to start our new business. Two hours later having chopped up an old pair of curtains, accidently sewn my jumper sleeve into the material and woken my husband up at 3am to our cackles, we had the first prototype of our Slumberpet Recovery Coat.
"Our business has grown nicely since then and we are still coming up with more ideas, albeit in a slightly more sober, professional manner."
To select and order your hobby kit, visit: https://www.vnpetproducts.co.uk/craft-corner
The research project, which is being carried out by RVC student Collette Taylor for her PhD, is looking at the development of novel diagnostic targets to establish the specific leptospira implicated in canine clinical cases.
Collette said: "Existing leptospirosis diagnostics have a number of limitations. MAT serological testing may provide information that can be supportive of a serogroup diagnosis but may also provide false positives due to previous vaccination or indeed be confounded by cross-reactivity. It can also be difficult to interpret serology in the absence of paired samples.
"PCR tests are sensitive, usually specific, but are dependent on timing of sampling and do not tell you which serovar is concerned.
"My research is focused on offering more specialised diagnostic tests which can differentiate antibodies associated with infection from those due to vaccination. Extending this theme, our group is interested in further typing of samples where the Leptospiral DNA is identified using Multi-locus sequence typing (MLST). I am now at the stage of validation and we are able to offer additional testing of serum or blood test samples from confirmed clinical cases."
If you'd like to send in a sample for further tests, you will need to complete a questionnaire, and samples must be from confirmed cases of leptospirosis that have already undergone leptospirosis diagnostics from another laboratory.
John Helps, Senior Technical Manager, Companion Animals, MSD Animal Health said: "As a 3rd year PhD student Collette has two main areas of study. The first is looking at the risk factors of leptospirosis including ecological niche modelling for specific serogroups in different regions across the country. The second part is the development of new specialised diagnostic tests that can provide better targeted serological approaches to diagnosis of this disease."
"As a potentially serious zoonosis, leptospirosis is an important differential diagnosis for a variety of canine disease presentations. These include not only acute renal or hepatic disease; it should also be on the differential list in conditions such as uveitis and retinal bleeding, acute respiratory distress, and haemorrhagic gastoenteritis when parvovirus is excluded.
"Collette's highly valuable research expands understanding of the epidemiology of canine leptospirosis within the UK. Veterinary practices that take advantage of this scheme will gain a better understanding of locally relevant disease data which is likely to better inform the approach to dog vaccination."
For further information contact Collette Taylor at ctaylor18@rvc.ac.uk.
BEVA President, Madeleine Campbell will be announcing plans for a veterinary-led European Transport Forum at BEVA Congress this year (8-11 September 2010), to discuss how the welfare of horses during transport can be improved through the better enforcement of legislation.
Dr Campbell is also the British Veterinary Association representative on the Federation of Veterinarians of Europe (FVE) working party for transport. The Forum, which will be held in Brussels on 29 November 2010, has been jointly organised by the FVE and BEVA and is sponsored by World Horse Welfare (WHW). It is hoped that it will be attended by over 150 participants, including representatives of EU Member States, CVOs, Members of the European Commission and European Parliament, scientific experts, national veterinary organisations, animal transport associations and animal welfare associations.
The Forum will review the enforcement of the existing European regulations that currently govern the transport of horses for slaughter and for other purposes. Areas for practical improvement will be identified with the key focus on the enforcement of current legislation and the role of vets in ensuring that the welfare of horses in transit is protected. The conference will endeavour to define the critical control points, effective control systems and good practices. It will also look into trade flows, animal health risks, horse identification and the effects of closing horse slaughterhouses.
Dr Campbell said: "It is all very well to campaign for new regulations but at present even the existing regulations are not being enforced adequately. The crux of the matter is enforcement and there are none better placed to help with this than vets. If we can all work collectively we should have the strength to make a real impact. This is what the Forum is about."
Dr Campbell will be speaking about the European Transport Forum at the Congress press conference on 10 September between 9am and 10am.
BEVA Congress runs from 8-11 September 2010 at the International Convention Centre, Birmingham. For further information and to register visit http://www.beva.org.uk/
Medivet senior partner Adi Nell says the profession needs to consider new business models to encourage more vets into ownership, as well as fresh approaches to supporting the role.
Responding to issues and recommendations highlighted in the latest VetFutures report, such as the number of female practice owners and a perceived lack of business skills in the profession, Adi said practices need to be flexible when it comes to attracting new vets or owners.
"Client expectations have changed drastically in the past 15 years, but so have the desires of potential practice owners. The world of clinical practice is changing at a rate we’ve never seen before. Owning a practice, along with the other increasing demands on our limited time and energy, is becoming more of a challenge too. This is evident with the growth of business support and development services, indicating an increased demand for that support.
"New practice owners aren’t like previous generations. Although traditional models of ownership are changing gradually, we also need different models of working, such as flexible hours, and different methods of support are needed."
One of the trends noted in the 2014 VetFutures report was how, despite dominating the profession in terms of overall numbers, women are still less likely to be a sole principal, director or partner.
Medivet claims an excellent track record here, with a near 50/50 split of male and female branch owners/partners.
Adi added: "We’re very happy to have so many women as business partners with us. The combination of clinical freedom, business support and a real feeling of teamwork and care for each other are some of the features that enable our partnership model to work so well. The scope for clinical and business development is huge, and we do our very best to look after all our people as they grow.
"However, there are still far too many bright, talented and highly trained vets leaving the profession after too short a time. Why do we turn these diamonds into coal? We need to understand what’s driving this and how we can adapt. The VetFutures report starts to offer some of the answers – and has uncovered even more questions!"
The VetFutures report also found aspirations of practice ownership or partnership dropped from 45% among students to 25% once vets start work. Adi says that offering opportunities for vets to expand into other areas of expertise is key to reducing the decline in appetite for practice ownership. He said: "I started out offering dermatology referral services to various Medivet branches before becoming a branch partner myself. I’m now in charge of a Medivet region of 16 practices as well as being involved in strategy, marketing, HR and operations, which I absolutely love, but never predicted I would do.
"I believe fewer and fewer vets see themselves doing the same job in clinical practice for their entire careers. That includes not wanting to be an employee for life, but also not wanting to have all the responsibility and burden of individual practice ownership. A big group like Medivet allows them to find the niche they enjoy and to develop the skills they value, to the benefit of their own careers, their business success, their client care and their patients’ health."
The Association says following the launch two years ago BEVApod has become such a popular information and learning resource that members have been asking for more content.
The new BEVApod will include regular features from equine vet Brad Hill, clinical Assistant Professor in Equine Practice at the University of Nottingham (pictured right), who will be exploring the many aspects of life in equine practice. He will be sharing real life stories to help promote a sense of togetherness and support mental health and wellbeing.
Brad said: “Although based at Nottingham, I am passionate about maintaining links to all areas of the equine profession. This podcast will provide a platform to bring the experiences of others directly to the listener wherever they are.”
Brad will be releasing a new episode every other week and has already lined up some participants, including Maddy Campbell, Ellen Singer, Graham Duncanson, Jack Wallace and Gemma Kirk.
BEVApod will also host clinical episodes on a monthly basis, taken from the BEVA Clinical Catch-Up recordings.
BEVA President Lucy Grieve said: “These are live webinars where we invite a practitioner to present on a clinical topic and then open it up for an informal discussion. We have turned the recordings of these into podcasts so that our members can listen to the recordings whilst travelling between clients. It makes great use of travel time and fills the void we all sometimes feel when we are alone with just our thoughts in the car.”
Current clinical catch-ups available on BEVApod include a panel discussion with experts on PPE, a discussion on equine obesity with Lucy Grieve and Cathy McGowan and treating and managing liver disease with Sarah Smith.
You can listen to the BEVApod here https://beva.podbean.com
Andra-Elena Enache and Savina Gogova join the head of service Richard Everson, an RCVS and European Recognised Specialist, to form one of the strongest ophthalmology teams in the UK.
Richard said: “It is fabulous that Andra and Savina were both successful in their specialist examinations.
“Of course, we already knew their expertise but passing the examination requires not just an unparalleled knowledge of their subject but also the constitution that allows them to prove their knowledge, skills and professionalism in the crucible of the examination environment.
“For both Andra and Savina to pass at the first time of asking is remarkable and just confirms their brilliance. It’s also a big boost for NDSR.
“Having three internationally-recognised specialists in ophthalmology in one hospital makes the service so much more resilient; for example, we will never have to close due to annual leave or lecturing commitments.
“This strength in depth means we really can offer the best possible service to our referring vets and poorly pets.”
For more information, visit: www.ndsr.co.uk.
The researchers, from the Dick Vet Equine Hospital, University of Edinburgh, Newcastle University, Istituto Zooprofilattico Sperimentale delle Venezie, and the University of Padova found that affected horses have major abnormalities in the structure of their neuromuscular junctions, microscopic sites of communication between nerves and muscles that are crucial for normal muscle function.
These abnormalities are believed to represent a toxin specific signature, effectively a ‘smoking gun’, for a neurotoxic enzyme termed a phospholipase A2.
Work is now underway to definitively identify the source of the toxin, in the hope that it will lead to novel treatments and improved diagnostics for this devastating disease.
The researchers think the toxin is likely to be produced by a microbe such as a bacterium or fungus growing on the horse’s pasture during the cold and dry weather which commonly precedes the disease.
Neurotoxic phospholipase A2 toxins are also present in the venom of many poisonous snakes, and there are many similarities between the signs of grass sickness and those of snake envenomation.
While there is no suggestion that venomous snakes cause grass sickness, it is hoped that some of the drugs that are currently being developed to treat and promote nerve regeneration in people paralysed by snake venoms can aid recovery of horses from grass sickness.
The researchers say that the neurotoxin most likely also causes the apparently identical diseases (termed animal dysautonomias) which affect cats, dogs, hares, rabbits, llamas, alpacas and sheep, and that their finding contradicts the previous leading hypothesis that grass sickness is a form of botulism.
This breakthrough is summarised in an editorial in the January 2025 issue of the Equine Veterinary Journal (EVJ).
The editorial, by Bruce McGorum and colleagues, looks at the implications of their article 'Equine grass sickness is associated with major abnormalities in the ultrastructure of skeletal neuromuscular junctions2".
Bruce said: “Identifying a probable cause of Equine Grass Sickness represents a significant breakthrough.
"We hope that this discovery will lead to novel treatments and improved diagnostics for this devastating condition.
"We are very grateful for the generous support we have received from horse owners, veterinary surgeons, scientists, charities and funding bodies.”
Bruce's editorial is currently available on Early View, free for 12 weeks, and will also be published in the January 2025 print issue of the EVJ.
Reference
The original survey was sent last year to more than 5,000 UK-registered veterinary surgeons and veterinary nurses who gained their qualification from a non-UK EU institution, with a response rate of around 55%.
This year the Institute for Employment Studies (IES), on behalf of the RCVS, contacted over 6,000 veterinary surgeons and almost 50 veterinary nurses – including those previously surveyed as well as EU registrants who have joined since the last survey – who trained in non-UK EU countries to seek their views on the implications of Brexit for European veterinary professionals.
Chris Tufnell, RCVS Senior Vice-President and Chair of the College’s Brexit Taskforce, said: "The aim of this survey is to gain a greater understanding of the views and expectations of our EU colleagues now that certain elements of the UK’s withdrawal process from the European Union, as well as the timing, have become clearer. The survey will also be looking for the views of colleagues on how the College has addressed the challenges of Brexit so far.
"It is particularly important that those who responded to last year’s survey do so this year because the aim is to get a sense of how their views and plans are shifting as the Brexit process moves forward."
As with last year’s survey, the views collated through the consultation will help the College understand the immediate and longer-term impact of the UK’s exit from the EU, gather evidence that could be used to make a case for special treatment of veterinary professionals with regard to future immigration policies and allow the College to provide informed advice to European veterinary professionals as they make decisions about their future careers.
Dr Tufnell added: "I would strongly encourage EU veterinary professionals to respond to this survey, even if they didn’t do so last year, as their views really do matter to us and really do have an impact on our Brexit policies and the views we put forward to the government in these critical times."
The deadline for sending responses to the IES is Wednesday 18 July 2018 and all data will be managed and analysed by IES, an independent not-for-profit research institute, on a confidential basis with no individual responses being seen by the RCVS.
The College says it intends to conduct a third survey when the terms of the UK’s withdrawal from the EU, and the impact of this on non-UK EU nationals, are better defined.
The study titled “Electrolyte measurements differ between point-of-care and reference analysers in dogs with hypoadrenocorticism” investigated the performance of two point-of-care analysers (IDEXX Catalyst Dx and IDEXX VetStat) against a reference laboratory method for the measurement of blood sodium, potassium and chloride concentrations, as well as sodium-to-potassium ratios, in dogs diagnosed with and treated for hypoadrenocorticism.
Forty-eight dogs with hypoadrenocorticism were enrolled into a prospective cross-sectional study at the University of Glasgow. In total, 329 paired samples were measured on the Catalyst analyser and by the reference laboratory method called an ion selective electrode (ISE), while another 72 paired samples were tested on both the VetStat analyser and by ISE. The clinical effects of any difference in the electrolyte results were investigated.
Sam Fowlie, corresponding author for the paper, said: “Our results indicate that the sodium, potassium and therefore the sodium-to-potassium ratios, as well as the chloride concentrations measured by the Catalyst and VetStat analysers may not be used interchangeably with those from a reference laboratory analyser using an indirect ISE method. Both analysers tended to give higher results than the reference method for all analytes, except for potassium when measured on the VetStat.”
The clinical relevance of the disagreement between these methods was investigated by assessing how often the point-of-care analysers produced results which fell outside their reference range when the ISE method found them to be within reference and vice versa. For the Catalyst, there were 21 cases (6%) with discordant sodium results, 27 cases (8%) with discordant potassium results and 46 cases (14%) with discordant chloride results. The VetStat, meanwhile produced results which disagreed with the ISE method in 19 cases (26%) for sodium, 3 cases (4%) for potassium measurement and 9 cases (13%) for chloride analysis.
Nicola Di Girolamo, Editor of JSAP added: “This study reveals significant systematic differences (“bias”) between the three analysers in this study. Comparing numerical results from different analytical methods – be they point-of-care or reference laboratories – can be dangerous for patients. Clinicians should always use method specific thresholds and, if these are not available (for example the sodium-to-potassium ratios on some analysers), then they should exercise greater caution in their interpretation.”
The full article can be found in the October issue of the Journal of Small Animal Practice and be read online here, open access: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13205.
Photo: Ian Ramsey
CEVA Animal Health and the University of Lincoln have presented three distance learning students on the university's pheromone therapy course with awards in recognition of their research into the benefits of pheromone therapy in combating behavioural problems in pets.
Veterinary nurse, Mandy Davis RVN, won first place and was presented with a cheque for £1,000 for her evaluation of the use of rabbit appeasing pheromones in a pet demonstrating fearful and aggressive behaviour towards its owner.
Second place and a cheque for £500 went to pet behaviourist and VetSurgeon member, Dr Carri Westgarth BSc(Hons) PhD from the University of Liverpool, for her case which reported on the use of D.A.P.® and clomipromine in a separation-related problem in a dog.
Third place and a cheque for £250 was awarded to veterinary surgeon, Graeme Buchan BVMS MRCVS, from Blackness Veterinary Centre in Dundee for his study into the use of a D.A.P.® Collar in the management of disruptive stress in the home.
"More and more pets are referred to animal behaviour experts each year and pheromone therapy is increasingly being used to help pets overcome behavioural issues such as aggression and separation anxiety," said Professor Daniel Mills, recognised specialist in veterinary behavioural medicine, at the University of Lincoln. "The students' case histories demonstrated their understanding of the benefits of pheromone therapy and how products that mimic the effects of naturally occurring pheromones can improve both the health and welfare of stressed pets. Many of the reports were of a very high standard, and showed a good understanding of the science behind the practice, which is so important for effective use."
The University of Lincoln launched the country's first accredited course in pheromone therapy in 2007 to help increase the veterinary profession's understanding of stress and its potential to trigger behavioural issues in pets. The distance learning course, which is supported by CEVA Animal Health, is aimed at veterinary surgeons, veterinary nurses and behaviourists and comprises 12 audio visual tutorials covering pheromone therapy and its applications in companion animals which can be undertaken at a pace to suit individual students.
Lucy Brett, product manager at CEVA Animal Health said: "The pheromone therapy course is a must for veterinary professionals wishing to learn more about behavioural problems in pets, including the stress triggers that can lead to disruptive and undesirable behaviour and the benefits of synthetic copies of natural pheromones in overcoming these issues."
The deadline for applications for the University of Lincoln's next Pheromone Therapy Course, which starts in February 2009, is 16 December 2008. For further information, please contact the University of Lincoln on 01522 882000 or visit www.lincoln.ac.uk.
Norbrook has launched palatable pork liver flavoured Carprieve tablets to help make dosing dogs a stress-free experience for dog and owner.
Offering Cox-2 preferential pain release, Carprieve Flavoured Tablets are indicated for chronic inflammation, such as degenerative joint disease in dogs, as well as post-operative pain management. According to Norbrook, tests have shown 75 per cent of dogs will take them voluntarily.
Sascha van Helvoort MRCVS, international veterinary adviser for Norbrook Laboratories, said: "Palatability is an important consideration for owners, especially for dogs with chronic inflammation, who often need regular tablets.
"Success is often hit-and-miss, with dogs leaving tablets given in food or spitting them out. This led to us testing pork liver tasting carprofen tablets on dogs who needed treatment, and the vast majority ate them from a bowl. This means vets can prescribe them with all confidence that the dogs will get their medicine.
Sascha added: "Studies undertaken by Norbrook covered a wide range of breeds, and included dogs from one year old to 14. In addition, the majority preferred the Pork liver flavour to top brand 'palatable' tablets.
"Getting the dosage right is also easy. That's why we decided to introduce our Carprieve Flavoured Tablets in blister packs rather than in tubs to aid dosage administration."
For more information, visit: http://www.norbrook.co.uk
The College has kicked off with questions and answers about the right to work in the UK and the impact on those currently studying to become a veterinary surgeon or planning to do so.
Although it's not yet possible to give definitive answers and there will doubtless be many more questions, the College says it will be keeping the new page updated as the situation unfolds.
The Q&A page can be found here: http://www.rcvs.org.uk/registration/about-the-rcvs-register/frequently-asked-questions-on-the-impact-of-the-eu-referendum/
This, says the company, will make vaccination easier for vets and clients.
Eravac is an injectable emulsion ready for administration without the need for reconstitution beforehand.
Each box contains 10 individual doses which can be given to pet rabbits from 30 days of age.
For the study, the RVC interviewed 13 small animal general practitioners, exploring their experience of providing pre-purchase consultations for brachycephalic dogs.
The study revealed a number of barriers to delivering effective pre-purchase consultations and advice about these breeds.
They included limited time and resources, competition for appointment availability, a perception that vets are only there to fix things, public distrust of veterinary surgeons (often over money), fear of damaging vet-client relationships, and the conflicting influence of breeders and the Kennel Club on clients.
Many veterinary surgeons that took part in the research felt that they had little or no power to overcome these barriers which are highly intractable at an individual veterinarian level.
A resulting moral conflict in veterinary surgeons between their perceived ethical and moral responsibilities to animal welfare versus the needs and wants of their clients and businesses was expressed by many vets in the study, and was felt to compromise their professional integrity and autonomy.
The study set out a series of recommendations:
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC and lead author of the study, said: “This is the first time that the impact of brachycephaly on the practising veterinary surgeon has been explored.
"Our concerning results highlight the importance of recognising that the brachycephalic crisis is not only negatively impacting animals, but it is affecting human wellbeing too.
“Our study highlights the conflict that vets are experiencing - bound both by their duty of care to their brachycephalic patients, but also to animal welfare at a population level.
"Trying to balance both of these responsibilities in the current working environment is proving very challenging for some, leading to moral distress.
"It is, therefore, essential that we protect the mental wellbeing of vets on this issue as well as from an animal welfare perspective.
“As the brachycephalic crisis continues to prevail, the support of leading veterinary organisations is vital in providing a united voice regarding the known harms of brachycephaly and support in facilitating PPCs to ensure vets are protected, and potential owners are fully informed when it comes to acquiring decisions.”
Dr Dan O’Neill, Assoc Prof of Companion Animal Epidemiology at the RVC and co-author of the study, said:
“Over the past decade, the RVC has generated a vast evidence base revealing the true extent of the serious health issues of dogs with brachycephaly.
"This new study now focuses RVC research towards protecting the wellbeing of practising veterinary surgeons who are also shown as victims of the brachycephalic crisis.
"The clear message here is that we all need to ‘stop and think before buying a flat-faced dog’.”
The Veterinary Wound Healing Association (VWHA) has become the third veterinary association to make a new home on VetSurgeon.org.
VWHA President Jacintha Wilmink said: "We're very excited about joining VetSurgeon.org and how it will allow our members to connect with each other and share information quicker and more easily than ever before".
In common with the other associations, the VWHA is making its content available for all VetSurgeon members to access, however only VWHA members can submit cases to its section for discussion, or participate in the VWHA forum. Jacintha added: "We hope that the cases and discussions in our section of the site will be of value to all practitioners, and that many more of you will want to join the association and participate".
Information about the benefits of joining the VWHA is available here.
Seven graduands from The University of Nottingham's School of Veterinary Medicine and Science have become the first from the new school to become members of the Royal College of Veterinary Surgeons.
Nottingham is the first new veterinary school in the UK for over 50 years, and the process to recognise its degree for the purposes of RCVS membership is currently in its final stages. Following a visitation and audit process, RCVS Council unanimously recommended the degree's approval to the Privy Council, where the final decision lies.
Generally, veterinary graduates become RCVS members - which they need to be in order to practise in the UK - at a ceremony on the day of their graduation. However, sometimes they wish to start work before graduation and can therefore apply to register as graduands, as in this case.
Although formal Privy Council approval of the Nottingham degree is still awaited, RCVS external examiners have overseen the School's final exams during the last year of the course to ensure that they meet the required standards.
The Nottingham graduation ceremony will take place on 22 July, when a further 77 students will graduate, and those wishing to practise in the UK will become members of the College.
The RCVS 2010 Survey of the Veterinary and Veterinary Nursing Professions indicated that, on average, new graduates took one month to find work on graduating, with 63% going straight into clinical practice.
Animalcare Ltd has launched Marbocare (marbofloxacin) 100mg/ml solution for injection, a third-generation fluoroquinolone for the treatment of E.coli mastitis and bovine respiratory disease (BRD) in cattle, and Metritis Mastitis Agalactia in pigs.
The company highlights the product's unique flexible dosage regimen of once daily injections for 3 days against E.coli mastitis and BRD, plus a single intramuscular (IM) high dose (8mg/100kg) for BRD.
Animalcare says this regimen, coupled with the flexibility of administration afforded by all three injection routes (intravenous IV, subcutaneous SC and IM), a low volume dose and good syringeability, all combine to offer ease of use; resulting in a reduction in handling and less stress for the cattle.
Developed for veterinary use only, Marbocare has broad spectrum activity against Gram+ve and Gram-ve pathogens. Animalcare says the product is especially effective against E.coli mastitis and the key bacterial pathogens associated with BRD, as well as M.bovis.
Marbocare has milk withdrawal times of 36 hours after the last treatment following the 3 day course and 72 hours after a single shot for BRD. Meat withdrawal is 6 days after multiple injections and 3 days after the single shot.
Marbofloxacin has proven efficacy in a comparative international, multi-centre, controlled, randomised field trial1 in 62 dairy cows with E.coli mastitis. Marbofloxacin cure rates were significantly higher than the control product. In respiratory disease it showed a more rapid clinical response in comparison to tilmicosin2, ceftiofur3 and oxytetracycline4. Marbofloxacin was shown to be well tolerated, leading to a fast return to appetite, liveweight gain and associated welfare benefits.
Marbocare is also licensed in the treatment of Metritis Mastitis Agalactia syndrome in pigs, given by IM injection, with a 4 day meat withdrawal.
Tony Liepman, Product Manager from Animalcare said: "Marbocare is competitively priced whether used on its own or alongside a single-dose anti-inflammatory such as Emdocam (meloxicam)."
Marbocare is a POM-V licensed product presented in 50 and 100ml multi-dose vials.
References
Zoetis has announced the launch of Apoquel (oclacitinib maleate), a new treatment for pruritus associated with canine allergic dermatitis and the clinical manifestations of atopic dermatitis.
Uniquely, the new treatment inhibits the JAK enzyme, a protein that is integral to the signalling pathway of cytokines that are pro-inflammatory or have a role in allergic and itch response.
According to the company, pruritus affects about one in six dogs whose owners seek veterinary help, and about half of all itchy dogs will have an underlying allergic skin condition for which the new product would be indicated.
Zoetis says that because Apoquel targets the specific pathways of pruritus (itch) and inflammation, it is less likely to cause unwanted side effects than glucocorticoids and demonstrates anti-pruritic efficacy within four hours.
Pascal Prélaud, a dermatology specialist from Paris, who took part in the clinical development programme of Apoquel, said: "When a dog develops an itch related to an allergy, it can be life-disrupting for the dog and the entire family. I've learned firsthand the fundamental difference this treatment can make to a dog and its owners in stopping the itch, but without many of the side-effects that are common with steroids.
Zoetis reports that in clinical trials, Apoquel demonstrated a good safety profile and efficacy for the treatment of pruritus and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners within 24 hours of administration, and pruritus continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinarians were significantly improved after one week and continued to improve long term during the studies (four months).
Apoquel is a POM. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium- to long-term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
The 2014 Vet Charity Challenge is now open and teams can register via the website at www.vetcharitychallenge.co.uk.
The event takes place on Saturday 27th September at St Francis School, Pewsey, near Marlborough in Wiltshire. The day consists of teams of four taking part in walking/running, cycling and kayaking, some orienteering as well as some mental and physical tasks. All the time trying to gain as many points as possible. Last year the event raised over £50,000 for the three selected animal based charities. In 2014 the charities being supported are Hearing Dogs for Deaf People, SPANA and Cats Protection.
Gavin Mitchell from BCF Technology said: "Interest in the Vet Charity Challenge was so great last year that we had teams on a waiting list. To ensure your team gets a place we highly recommend that you register your team on the website early. We will be entering five teams from BCF this year, such is the demand from our own staff."
Andrew Groom from Kruuse added: "The Vet Charity Challenge is a great event. Helping you build your team within your veterinary practice, acting as a goal for those that want to become a bit fitter, encouraging training together over the summer months. It is great fun and also raises considerable sums of money for some really deserving charities. Don't delay, get your teams together and register now on the website. The event is designed for all levels of fitness. It is not the fittest team that wins, but the team that works the best together."
John Alborough presented the awards at the event. Liz Rawlings from Dechra said: "It was certainly a whirlwind at this year’s LVS and we are delighted to have scooped such a prestigious award." Zoe Appleyard-Ley, Co-Founder and Managing Director at Rockster Superfood for Dogs said: "We were so excited by the response Rockster had at the London Vet Show, and thrilled to have been given the award by VetSurgeon.org."
His most recent case was five-year-old bulldog called Jesse.
Guillaume said: "Jesse was suffering from both atlantoaxial instability and a spinal arachnoid diverticulum in the thoracic spine.
“As a result of the two conditions, he had lost a lot of mobility and was dragging his hind legs behind him.
“We decided it was best to carry out two separate operations, prioritising the surgery to tackle the atlantoaxial instability as that was potentially life-threatening.
“I used a new technique for this, adopting a dorsal approach, which involves an insertion through the top of the neck when normally this type of surgery is generally performed ventrally, through the bottom of the neck.
“We have had great success with this approach so far.
"The normal mortality rate is between 5 to 10%, however, we have now done 20 of these procedures together with colleagues, all of which have been successful.
“The main advantage of the technique is it likely reduces the risk of complications, which is why I prefer it.
“With the ventral approach you go through the soft tissue and nerves in the neck which brings the risk of vomiting, regurgitation, megaesophagus, swelling and even tracheal injury.” =
Guillaume has co-authored a publication on the dorsal surgical technique which can be found at: https://doi.org/10.3390/life11101039
Gerry, who joined North Downs in 2008, has been clinical director at the hospital since 2012.
He has published scientific literature and lectured across the world on a range of cancer subjects including lymphoma, mast cell tumours, lung tumours, insulin-producing tumours and novel anti-cancer therapies.
He also chairs and participates in a number of European oncology research projects and has a particular interest in collaborative clinical research.
Gerry said: “I’m delighted to be taking on this role, working alongside an incredibly talented and committed team.
“NDSR has achieved so much over the years, not only with cutting-edge treatments and procedures, but also with the implementation of an innovative new nursing structure, an industry-leading internship programme and being among the first veterinary hospitals to achieve a Green iiE award, to name just a few.
Talking about his main aims for the new role, Gerry said: “I want to create opportunities for our amazing team to develop into leadership roles, giving more autonomy to individual services and improving communication between services and management.
“From a care quality perspective, we always want to improve, and I look forward to harnessing innovative ideas and tools that might lead to better outcomes for pets and their families.
https://www.ndsr.co.uk.
The Disciplinary Committee of the Royal College of Veterinary Surgeons has dismissed a case against a veterinary surgeon from Kent having found him not guilty of serious professional misconduct.
Mr Francois-Guillame Saulnier-Troff - formerly an employee of North Kent Referrals in Blue Bell Hill near Aylesford - was charged with concealing from his clients that a fragment of metal had been left in their dog's body following surgery, and omitting any reference to that in the clinical records or notes.
At the hearing, the Committee heard that, during spinal surgery on Pippin, a Jack Russell terrier belonging to Mr and Mrs Bowers, a small metal fragment broke off a palpator and became lodged in the bony material. Mr Saulnier-Troff was unable to retrieve it.
However, Mr Saulnier-Troff did not inform Pippin's owners of this occurrence, either during the telephone conversation on the 15th of January immediately following the operation, or when he met with them for Pippin's post-operative check on the 2nd of February. He said that he had intended to discuss the fact with the owners when the dog was discharged and had requested that he be contacted when the owners came into the surgery. He had not been contacted, though, and on attending the practice two days later, found that Pippin had already been returned to his owners.
It was accepted by the Committee that Mr Saulnier-Troff had not considered the fragment of clinical significance, and that telling Mr and Mrs Bowers about it was not at the front of his mind at their subsequent meeting.
The Committee heard there was no reference to the fragment included in the clinical notes, discharge summary or referral report, but accepted that the discharge summary had not been prepared by Mr Saulnier-Troff and that the referral report had been drawn up and sent out without Mr Saulnier-Troff's approval or personal signature.
In their findings, the Committee made no criticism of Mr Saulnier-Troff for the breakage or non-retrieval of the fragment, concluding that he came across as a skilled and conscientious veterinary surgeon and that he was fundamentally honest. The Committee also described as "honest and straightforwards throughout," the accounts given by Mr and Mrs Bowers of their recollections of events. The Committee noted that Mr Saulnier-Troff had admitted that he ought to have told Mr and Mrs Bowers about the fragment and that he ought to have included details in the clinical notes.
Disciplinary Committee Chairman Mrs Alison Bruce said that they were "highly critical of the fact that Mr Saulner-Troff did not inform Mr and Mrs Bowers at any time of what had occurred or check that the clinical records had been completed either post-operatively or at the follow-up examination."
"The matters, which Mr Saulnier-Troff has admitted, flow from a failure on his part to speak to Mr and Mrs Bowers after the discharge had taken place and to check that he had completed a full clinical record which included reference to part of the palpator being left in Pippin's body,"
Mrs Bruce continued, adding that this was "indeed conduct which falls short of the standard to be expected. However, in the opinion of this Committee his conduct does not fall so far short that it amounts to disgraceful conduct in a professional respect."
Mrs Bruce concluded: "In these circumstances, the charge is dismissed."
The British Veterinary Association has announced the results of the Voice of the Veterinary Profession survey, which found that 84% of veterinary surgeons give up time to work with animal charities and shelters.
72% have a formal arrangement with charities to provide their time and veterinary expertise at a reduced rate, while more than 43% work completely unpaid for animal charities and shelters; treating thousands of abandoned, mistreated or injured animals each year.
The charitable work undertaken by practitioners varied from practice to practice, but included:
On top of all that, veterinary surgeons also provide emergency treatment for stray and wild animals brought in by the public. Although they will sometimes receive a charitable donation towards the cost of treatment through schemes like the RSPCA Initial Emergency Treatment (IET) Scheme, that is by no means always the case.
RSPCA Chief Veterinary Officer James Yeates said: "Vets’ work in this area can go unrecognised but it is appreciated by the RSPCA that they are part of the team trying to help animals. The RSPCA is dedicated to helping animals most in need and relies on vets’ welfare work to help bring a stop to the suffering of all animals."
BVA President Sean Wensley, said: "Behind these statistics are countless stories of veterinary teams – who already often work long, demanding hours – giving their time for free to support animal rescue staff and charities to care for abandoned, injured and neglected animals, as well as help owners to keep and care for much loved animals in times of hardship and crisis. The UK’s network of animal charities and rehoming centres do a fantastic job protecting wild and domestic animals each year. Animal welfare legislation is clear that animal keepers and owners are responsible for meeting their animals’ needs, and prospective animal owners must be aware of the cost and time commitment involved in animal ownership, but we appreciate people’s circumstances can change."
Photo: Javier Brosch/Shutterstock
The new service will offer all the chemo and surgical options.
Matthew (pictured right) said: "At Eastcott, we have amazing facilities and staff to care for pets with cancer, so we are proud to launch this comprehensive new oncology service.
"We have a custom-designed chemotherapy room, multiple sterile theatres - including our interventional radiology theatre - and state-of-the-art imaging facilities, with a 64-slice CT scanner and advanced ultrasound equipment.
"We are able to manage the full range of tumour types including maxillofacial tumours, from diagnosis to treatment.
"We use a variety of techniques to allow accurate staging, including minimally invasive biopsy and lymph node harvesting, as well as sentinel lymph node mapping and advanced medical imaging.
"Treatment options include advanced soft tissue surgical oncology and the full range of medical oncology. This may involve standard and metronomic chemotherapy, intracavitary chemotherapy and immunotherapy, such as the melanoma vaccine.
"We pride ourselves on helping owners understand our treatment plan through the whole process and emphasise the importance of making the right decisions to maintain the welfare of our patients.”
For more information, visit www.eastcottreferrals.co.uk.